Journal
CURRENT SURGERY REPORTS
Volume 5, Issue 12, Pages -Publisher
SPRINGER
DOI: 10.1007/s40137-017-0194-1
Keywords
Breast cancer; Immunotherapy; Cancer vaccines; Chimeric antigen receptor T cells (CAR T); Immune checkpoint; Oncolytic viruses
Categories
Funding
- NCI NIH HHS [P30 CA010815, P01 CA214278] Funding Source: Medline
Ask authors/readers for more resources
Purpose of Review The breast tumor microenvironment is immunosuppressive and is increasingly recognized to play a significant role in tumorigenesis. A deeper understanding of normal and aberrant interactions between malignant and immune cells has allowed researchers to harness the immune system with novel immunotherapy strategies, many of which have shown promise in breast cancer. This review discusses the application of immunotherapy to the treatment of breast cancer. Recent Findings Both basic science and clinical trial data are rapidly developing in the use of immunotherapy for breast cancer. The current clinical trial landscape includes therapeutic vaccines, immune checkpoint blockade, antibodies, cytokines, and adoptive cell therapy. Summary Despite early failures, the application of immunotherapeutic strategies to the treatment of breast cancer holds promise.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available